Cargando…

Editorial: Novel Molecular Targets and Treatments for Gastroesophageal Cancer

Detalles Bibliográficos
Autores principales:	Lam, Alfred King-yin, Li, Bin, Liang, Linhui, Xie, Jianjun, Xu, Wen Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136978/ https://www.ncbi.nlm.nih.gov/pubmed/35646716 http://dx.doi.org/10.3389/fonc.2022.888861

Ejemplares similares

Editorial: Establishment of marker models for molecular typing of renal cell carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?
por: Bai, Rilan, et al.
Publicado: (2020)

Editorial: Radiotherapy for esophageal cancer: Molecular mechanism and novel targets to improve radiosensitivity
por: Liu, Yanqing, et al.
Publicado: (2023)

Editorial: Novel targets for ovarian cancer stem cells
por: Wang, Yinu, et al.
Publicado: (2023)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers
por: Lu, Ziwen, et al.
Publicado: (2022)

Editorial: Advances in molecular targeted therapies of urologic cancers
por: Nitzsche, Bianca, et al.
Publicado: (2022)

Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms
por: Lim, Ken-Hong, et al.
Publicado: (2021)

Editorial: Novel Targets and Targeting Technologies to Modulate Tumor Microenvironment
por: Prakash, Jai, et al.
Publicado: (2016)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets
por: Cavallari, Ilaria, et al.
Publicado: (2023)

Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening
por: Hou, Jue, et al.
Publicado: (2022)

Editorial: Advances in the understanding and treatment of cutaneous lymphoma
por: Bernardelli, Andrea, et al.
Publicado: (2023)

Editorial: Multi-target directed ligands for the treatment of cancer
por: Brindisi, Margherita, et al.
Publicado: (2022)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
por: Sundar, Raghav, et al.
Publicado: (2020)

Editorial: Novel Combination Therapies for the Treatment of Solid Cancers
por: Ayoub, Nehad M.
Publicado: (2021)

Editorial: Novel targeted drugs for indolent lymphoid malignancies
por: Robak, Tadeusz, et al.
Publicado: (2023)

Editorial: Optical Molecular Imaging in Cancer Research
por: Zhang, Guanglei, et al.
Publicado: (2022)

Editorial: Molecular mechanisms of epithelial-mesenchymal transition in cancer metastasis
por: Amin, Amr, et al.
Publicado: (2022)

Editorial: Molecular Advances in Diagnosis and Treatment of CNS Tumors
por: Zhang, Zhao-Hui, et al.
Publicado: (2020)

Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment
por: Zhang, Ruowen, et al.
Publicado: (2022)

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors
por: Suenaga, Yusuke, et al.
Publicado: (2021)

Editorial for the series on gastric and gastroesophageal cancer treatment in 2020
por: Almhanna, Khaldoun
Publicado: (2020)

Editorial: Advances and novel technologies in surgical instruments for the treatment of cancer
por: Schuler, P.J., et al.
Publicado: (2022)

Editorial: Stress response signaling in tumor development and its implications for cancer treatment
por: Wen, Danwan, et al.
Publicado: (2022)

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II
por: Sharad, Shashwat, et al.
Publicado: (2023)

Editorial: The Molecular Basis of Somatic Evolution
por: Li, Qiyuan, et al.
Publicado: (2022)

Analysis of Immune Microenvironment by Multiplex Immunohistochemistry Staining in Different Oral Diseases and Oral Squamous Cell Carcinoma
por: Qiao, Bin, et al.
Publicado: (2020)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

Editorial: Molecular Diagnostics of Pediatric Cancer
por: He, Jing, et al.
Publicado: (2021)

Editorial: Molecular Biomarkers for Gastric Cancer
por: Hong, Xinqiang, et al.
Publicado: (2022)

Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements
por: Cann, Christopher G., et al.
Publicado: (2023)

Editorial: The molecular mechanisms of metastasis and therapeutic resistance in breast cancer
por: Liang, Yuanke, et al.
Publicado: (2023)

The Combination of Novel Targeted Molecular Agents and Radiation in the Treatment of Pediatric Gliomas
por: Dasgupta, Tina, et al.
Publicado: (2013)

Dual-layer dual-energy CT for improving differential diagnosis of squamous cell carcinoma from adenocarcinoma at gastroesophageal junction
por: Wu, Meihong, et al.
Publicado: (2022)

Editorial: Molecular characteristics and personalized treatment for pediatric brain tumors
por: Feng, Weijun, et al.
Publicado: (2022)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
por: Wang, Jianzheng, et al.
Publicado: (2022)

Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers
por: Kastelowitz, Noah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pokdis0obbmaqfve47rnofajv5